A Trial of Lu AG13909 in Adult Participants With Cushing's Disease

Summary

This trial will evaluate the effects of Lu AG13909 in adult participants with Cushing's disease (CD). CD is a rare and serious disorder where the body makes too much of a hormone called cortisol. The main goals of this trial are to learn about 1. the effect of Lu AG13909 on cortisol levels. 2. the safety and tolerability of Lu AG13909. 3. the pharmacokinetic parameters of Lu AG13909 (how the drug is absorbed, distributed, and processed by the body).

Timeline

Start

2024-06-19

Primary completion

2026-09-15

Completion

2027-10-31

Drugs

Indications